Piper Jaffray Continues to Expand its Health Care Franchise in the United Kingdom
May 10 2006 - 11:56AM
PR Newswire (US)
MINNEAPOLIS and LONDON, May 10 /PRNewswire-FirstCall/ -- Piper
Jaffray Companies (PJC) United Kingdom subsidiary, Piper Jaffray
Ltd., is pleased to announce the expansion of its health care
business in the UK with the additional hires of two investment
bankers and two research analysts. The new dedicated health care
personnel will increase the firm's presence in the UK and provide
enhanced services for clients. "We are thrilled to have these new
professionals join our team as we strive to expand our services to
health care clients in the UK," said David Wilson, chief executive
officer of Piper Jaffray Ltd. "These four individuals will provide
valuable expertise in both investment banking and research, which
will enable us to continue to grow our franchise." Joining Piper
Jaffray are Neil Mackison and Rupert Winckler in investment
banking. Mackison is a managing director and previously was the
head of European Health Care Investment Banking at ING. He joins
the firm with more than 18 years of experience in corporate
finance, focusing on the UK health care sector. Mackison has a
degree in chemistry from Kings College and is qualified as a
chartered accountant at Coopers and Lybrand in London. Winckler is
an associate investment banker and also joins from ING, where he
was part of the health care investment banking. He has a degree in
biochemistry from Oxford University. In research, Sally Bennett and
Richard Parkes join the firm as senior research analysts, covering
biopharmaceutical companies. Bennett was a director at ING
Wholesale Bank, where she was part of the biotechnology research
team. She holds a medical degree from the University of Manchester.
Parkes previously was a vice president at ING Wholesale Bank, where
he was part of the biotechnology research team. He has a Ph.D. in
molecular genetics from the Liverpool School of Tropical Medicine.
Piper Jaffray has had a presence in London since 1987 and Piper
Jaffray Ltd. was established in 1998. Last year, the firm announced
the strategic hire of 14 health care professionals in investment
banking, sales, trading and research, nearly doubling the size of
its presence in the United Kingdom. In addition, Piper Jaffray Ltd.
commenced trading as a member firm of the London Stock Exchange
(LSE) late last year and acts in a principal and agency capacity
and as a market maker in UK domestic securities. The firm currently
makes a market in 31 London Stock Exchange Full and AIM-listed
companies. Piper Jaffray Companies (NYSE:PJC) is a focused
securities firm dedicated to delivering superior financial advice,
investment products and transaction execution within selected
sectors of the financial services marketplace. The company
currently operates through two primary revenue-generating segments:
Capital Markets and Private Client Services. The sale of the
company's Private Client Services branch network, announced April
11, 2006, currently is pending. The company's Capital Markets
business generates revenue through two groups: Corporate and
Institutional Services and Public Finance Services. Through its
chief operating subsidiary in the U.S., Piper Jaffray & Co.,
the firm has served corporations, government and non-profit
entities, institutional investors and the financial advisory needs
of private individuals since 1895. With headquarters in
Minneapolis, Piper Jaffray currently has approximately 2,800
employees in 107 offices in 23 states across the country and in
London. The firm's UK operating subsidiary, Piper Jaffray Ltd., is
authorized and regulated by the Financial Services Authority and is
a member of the London Stock Exchange. For more information about
Piper Jaffray, visit us online at http://www.piperjaffray.com/ .
DATASOURCE: Piper Jaffray Companies CONTACT: Susan Beatty, Media
Relations of Piper Jaffray & Co., +1-612-303-5680, or, David
Bick of Holborn, +44 (0) 207 929 5599 Web site:
http://www.piperjaffray.com/
Copyright
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Jul 2023 to Jul 2024